Guide and Support for Orphan Drug Companies

Orphan Now is a consulting and partnering organization that guides and supports orphan drug companies in their quest to develop and commercialize therapies needed by patients with rare diseases.

Orphan Now consulting approach is based on

Orphan Now consulting approach is based on

  • Patient focus
  • Passion for results
  • Sense of urgency
  • The power of granularity. We focus on the details because each case presents different challenges and opportunitites
  • Experience, experience, experience
Learn more

Focus

Orphan Now enables our orphan drug client companies to capitalize on experienced in-market senior talent and capabilities early and quickly.

Orphan Now consulting approach is based on

Who we are

We are a network of independent, highly successful rare disease business leaders and experts.

Jordi Badia

Jordi Badia Founding Partner

With a successful business career in life sciences spanning over twenty-five years, Jordi is a se [..]

More info
Mark Barrett

Mark Barrett Partner

Mark has more than thirty years of experience in the pharmaceutical industry, with the last fifte [..]

More info
Catharina Järlhem

Catharina Järlhem Partner

Catharina Järlhem boasts over two decades of international portfolio and program management exper [..]

More info
Hans-Peter Halbritter

Hans-Peter Halbritter Partner

Hans Peter Halbritter looks back on more than twenty-seven years of experience as a commercial bi [..]

More info
Anders Kärnell

Anders Kärnell Partner

Anders is a Medical Doctor with extensive experience in pharma/biotech, spanning rare diseases, o [..]

More info
Robert-Jan Van Son

Robert-Jan Van Son Partner

Robert-Jan is a results-driven biotech leader with deep expertise in supporting biotech companies [..]

More info